Does adverse muscle composition increase the risk of all-cause mortality in individuals with NAFLD?
Measuring muscle health (volume and fat content) in NAFLD patients could help in the early detection of high-risk individuals and enable targeted preventative care.
Individuals with fatty liver disease and poor muscle health more often suffer from poor functional performance and comorbidities. This study shows that they are also at a higher risk of dying. The study results indicate that measuring muscle health (the patient's muscle volume and how much fat they have in their muscles) could help in the early detection of high-risk patients and enable targeted preventative care.
Linge et al. (Sat,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: